Sonal Singh to United States Food and Drug Administration
This is a "connection" page, showing publications Sonal Singh has written about United States Food and Drug Administration.
Pradhan R, Singh S. Comparison of Data on Serious Adverse Events and Mortality in ClinicalTrials.gov, Corresponding Journal Articles, and FDA Medical Reviews: Cross-Sectional Analysis. Drug Saf. 2018 Sep; 41(9):849-857.
Singh S. The Safety of Generic Prescription Drugs in the United States. Drug Saf. 2018 Apr; 41(4):325-328.
Iyer G, Marimuthu SP, Segal JB, Singh S. An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting System. Drug Saf. 2017 09; 40(9):799-808.
Marimuthu SP, Iyer G, Segal JB, Singh S. Patient-relevant outcomes associated with generic tamsulosin, levothyroxine and amphetamine in the FDA Adverse Event Reporting System: a pilot study. J Comp Eff Res. 2017 Jul; 6(5):437-447.
Moore TJ, Singh S, Furberg CD. The FDA and new safety warnings. Arch Intern Med. 2012 Jan 09; 172(1):78-80.